In a recent industry report focused on Biotechnology stocks, particularly those innovating in neurology and psychiatry, ...

BofA Securities made an adjustment to the price target for Altria stock, bringing it down to $61 from the previous $65, while still maintaining a Buy rating on the shares. This change was announced by ...

DURECT Corporation (Nasdaq: DRRX) today announced the publication of a peer-reviewed article on the AHFIRM trial data in NEJM ...

We recently published an article titled Jim Cramer Discusses These 18 Stocks & President Trump’s $500 Billion AI Plan. In ...

GI Innovation announced on the 20th that it has signed a memorandum of understanding (MOU) with the Chinese bio company ...

President Donald Trump’s pick to lead the U.S. Department of Agriculture said during her confirmation hearing Thursday that ...

We recently compiled a list of the 8 Best Humane Stocks to Invest in Now. In this article, we are going to take a look at ...

The ASX 200 benchmark touched an all-time record of 8566 points before pulling back slightly. At around lunch time Friday, ...

Mr. John DeLucia, as a well-respected Regulatory Consultant, is representing Izotropic in its pre-submission interactions with FDA while ensuring the Company's proposals, documentation, filings, and ...

The Trump administration’s budget freeze on federal grants and loans will affect more than 2,600 accounts across the ...

European markets closed higher on Friday, buoyed by robust Chinese growth data and merger talks in the mining sector.